Multivalent antigen display on nanoparticle immunogens increases B cell clonotype diversity and neutralization breadth to pneumoviruses
2023 · Immunity · 64 citations
https://doi.org/10.1016/j.immuni.2023.08.011
R
Rodrigo Arcoverde Cerveira
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
24
Papers
262
Citations
7
h-index
6
i10-index
Rodrigo Arcoverde Cerveira is an academic researcher from Karolinska University Hospital. The author has contributed to research in topics: Immunotherapy and Immune Responses & SARS-CoV-2 and COVID-19 Research & T-cell and B-cell Immunology. The author has an h-index of 7, co-authored 21 publications.
ORCID: 0000-0002-1145-2534Papers by this author
worksUnmodified rabies mRNA vaccine elicits high cross-neutralizing antibody titers and diverse B cell memory responses
2023 · Nature Communications · 46 citations
https://doi.org/10.1038/s41467-023-39421-5
A third dose of the unmodified COVID-19 mRNA vaccine CVnCoV enhances quality and quantity of immune responses
2022 · Molecular Therapy — Methods & Clinical Development · 43 citations
https://doi.org/10.1016/j.omtm.2022.10.001
Three immunizations with Novavax’s protein vaccines increase antibody breadth and provide durable protection from SARS-CoV-2
2024 · npj Vaccines · 25 citations
https://doi.org/10.1038/s41541-024-00806-2
Low Annexin A1 level in HTLV-1 infected patients is a potential biomarker for the clinical progression and diagnosis of HAM/TSP
2021 · BMC Infectious Diseases · 7 citations
https://doi.org/10.1186/s12879-021-05917-y
Scifer: An R/Bioconductor package for large-scale integration of Sanger sequencing and flow cytometry data of index-sorted single cells
2024 · ImmunoInformatics · 1 citations
https://doi.org/10.1016/j.immuno.2024.100046
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat